SMFM Statement: The Choice of Progestogen for the Prevention of Preterm Birth in Women with Singleton Pregnancy and Prior Preterm Birth
The Society for Maternal-Fetal Medicine (SMFM) has released a statement addressing the use of 17-alpha hydroxyprogesterone caproate (17-OHPC) therapy to prevent preterm birth (PTB) out of concern that women who…